Recombinant Dengue Type 2 Viruses with Altered E Protein Domain III Epitopes Are Efficiently Neutralized by Human Immune Sera
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant Dengue Type 2 Viruses with Altered E Protein Domain III Epitopes Are Efficiently Neutralized by Human Immune Sera
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 86, Issue 7, Pages 4019-4023
Publisher
American Society for Microbiology
Online
2012-01-26
DOI
10.1128/jvi.06871-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
- (2011) Ruklanthi de Alwis et al. PLoS Neglected Tropical Diseases
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections
- (2010) S. Ubol et al. Clinical and Vaccine Immunology
- Domain III of the envelope protein as a dengue vaccine target
- (2010) Maria G Guzman et al. Expert Review of Vaccines
- Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
- (2010) James D. Brien et al. JOURNAL OF VIROLOGY
- An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection
- (2010) C. M. Midgley et al. JOURNAL OF VIROLOGY
- Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2
- (2010) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- Dengue: a continuing global threat
- (2010) Maria G. Guzman et al. NATURE REVIEWS MICROBIOLOGY
- Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354
- (2010) B. Kaufmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
- (2010) Olivia K.T. Block et al. VACCINE
- Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes
- (2010) Steven M. Erb et al. VIROLOGY
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
- (2010) Bimmi Shrestha et al. PLoS Pathogens
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
- (2009) W.M.P.B. Wahala et al. VIROLOGY
- The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion
- (2009) Claire Y.-H. Huang et al. VIROLOGY
- Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development
- (2008) Theodore C. Pierson et al. Cell Host & Microbe
- Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
- (2008) G. D. Gromowski et al. JOURNAL OF VIROLOGY
- Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
- (2008) Shee-Mei Lok et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III
- (2008) Kiyohiko Matsui et al. VIROLOGY
- Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization
- (2008) Steevenson Nelson et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started